Eric D. Shaff's Net Worth
$556 Thousand
Who is Eric D. Shaff?
Eric D. Shaff does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Seres Therapeutics, Inc., and Sigilon Therapeutics, Inc..
SEC CIK
Eric D. Shaff's CIK is 0001643734
Past Insider Trading and Trends
2016 was Eric D. Shaff's most active year for acquiring shares with 7 total transactions. Eric D. Shaff's most active month to acquire stocks was the month of December. 2016 was Eric D. Shaff's most active year for disposing of shares, totalling 13 transactions. Eric D. Shaff's most active month to dispose stocks was the month of December. 2022 saw Eric D. Shaff paying a total of $199,999.80 for 572,380 shares, this is the most they've acquired in one year. In 2016 Eric D. Shaff cashed out on 58,476 shares for a total of $798,141.03, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Seres Therapeutics, Inc. (MCRB) Snapshot price: $1.025
CEO and President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +3.97% | 5.38K |
$0.94 | -$2,288.90 | 140.7K |
May 15
| |||
Form 4
| +17.04% | 19.7K |
$1.08 | -$12,472.92 | 135.32K |
Feb 14 - Feb 16
| |||
Form 4
| +20.02% | 19.29K |
$1.35 | -$11,545.20 | 115.62K |
Scheduled
|
Apr 27 - Oct 30
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 4
| +193.33% | 63.49K |
$3.15 | $199,999.80 | 96.33K |
Jul 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
| +155.74% | 20K |
—
|
—
| 32.84K |
Jan 26
| |||
Form 4
| +146.02% | 7.62K |
$5.75 | -$25,187.51 | 12.84K |
Jan 25 - Jan 28
| |||
Form 4
|
∞
| 5.22K |
$11.02 | -$30,635.60 | 5.22K |
Jan 26 - Jan 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
|
—
|
0
|
$18.67 | -$98,592.75 |
0
|
Scheduled
|
Jun 30
| ||
Form 4
|
—
|
0
|
$18.04 | -$102,487.16 |
0
|
Scheduled
|
Jun 27 - Jun 28
| ||
Form 4
|
—
|
0
|
$18.32 | -$138,322.08 |
0
|
Scheduled
|
Apr 4
| ||
Form 4
|
—
|
0
|
$17.05 | -$141,874.58 |
0
|
Scheduled
|
Mar 31
| ||
Form 4
|
—
|
0
|
$15.93 | -$89,100.44 |
0
|
Scheduled
|
Mar 28
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sigilon Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||